SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-118633
Filing Date
2024-11-14
Accepted
2024-11-14 12:19:26
Documents
1
Group Members
HEIGHTS CAPITAL MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2428264d5_sc13ga.htm SC 13G/A 58447
  Complete submission text file 0001104659-24-118633.txt   60299
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88372 | Film No.: 241459293
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8080
CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings)

IRS No.: 981253664 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A